High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE)

Lupus

Volumn 22, Issue 6, 2013, Pages 597-606

  Abdulahad, D A ^a   Westra, J ^a   Reefman, E ^b   Zuidersma, E ^a   Bijzet, J ^a   Limburg, P C ^a   Kallenberg, C G M ^a   Bijl, M ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b TNO   (Netherlands)

^c MARTINI HOSPITAL   (Netherlands)

Author keywords

HMGB1; skin; SLE

Indexed keywords

CASPASE 3; CD3 ANTIGEN; CHLORDANE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MYXOVIRUS RESISTANCE PROTEIN A;

ADULT; APOPTOSIS; ARTICLE; CELLS; CLINICAL ARTICLE; CYTOKINE RELEASE; DERMATITIS; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; RADIATION EXPOSURE; SKIN BIOPSY; SUNBURN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET B RADIATION;

HMGB1; SKIN; SLE;

ADULT; APOPTOSIS; BIOPSY; CASE-CONTROL STUDIES; CASPASE 3; FEMALE; HMGB1 PROTEIN; HUMANS; INFLAMMATION; KERATINOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHOTOSENSITIVITY DISORDERS; SKIN; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 84878307338     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313483377     Document Type: Article

References (33)

1. Skov L, Hansen H, Allen M, et al. Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin. Br J Dermatol. 1998 ; 138: 216-220
2. Yoshizumi M, Nakamura T, Kato M, et al. Release of cytokines/chemokines and cell death in UVB-irradiated human keratinocytes, HaCaT. Cell Biol Int. 2008 ; 32: 1405-1411
3. Kuhn A, Herrmann M, Kleber S, et al. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum. 2006 ; 54: 939-950
4. Reefman E, de Jong MC, Kuiper H, et al. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?. Arthritis Res Ther. 2006 ; 8: R156 - R156
5. Gaipl US, Kuhn A, Sheriff A, et al. Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun. 2006 ; 9: 173-187
6. Bell CW, Jiang W, Reich CF, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol. 2006 ; 291: C1318 - C1325
7. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994 ; 179: 1317-1330
8. Harris HE, Andersson U, Pisetsky DS. HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol. 2012 ; 8: 195-202
9. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002 ; 418: 191-195
10. Chen G, Li J, Ochani M, et al. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J Leukoc Biol. 2004 ; 76: 994-1001
11. Kokkola R, Andersson A, Mullins G, et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol. 2005 ; 61: 1-9
12. Tian J, Avalos AM, Mao SY, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007 ; 8: 487-496
13. Yu M, Wang H, Ding A, et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock. 2006 ; 26: 174-179
14. Park JS, Gamboni-Robertson F, He Q, et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol. 2006 ; 290: C917 - C924
15. Voll RE, Urbonaviciute V, Herrmann M, Kalden JR. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. Isr Med Assoc J. 2008 ; 10: 26-28
16. Urbonaviciute V, Furnrohr BG, Meister S, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE. J Exp Med. 2008 ; 205: 3007-3018
17. Urbonaviciute V, Meister S, Furnrohr BG, et al. Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis. Autoimmunity. 2009 ; 42: 305-307
18. Barkauskaite V, Ek M, Popovic K, Harris HE, Wahren-Herlenius M, Nyberg F. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus. 2007 ; 16: 794-802
19. Popovic K, Ek M, Espinosa A, et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum. 2005 ; 52: 3639-3645
20. Lokitz ML, Billet S, Patel P, et al. Failure of physiologic doses of pure UVA or UVB to induce lesions in photosensitive cutaneous lupus erythematosus: Implications for phototesting. Photodermatol Photoimmunol Photomed. 2006 ; 22: 290-296
21. Reefman E, Kuiper H, Jonkman MF, Limburg PC, Kallenberg CG, Bijl M. Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes. Rheumatology (Oxford). 2006 ; 45: 538-544
22. Kuhn A, Wozniacka A, Szepietowski JC, et al. Photoprovocation in cutaneous lupus erythematosus: A multicenter study evaluating a standardized protocol. J Invest Dermatol. 2011 ; 131: 1622-1630
23. Reefman E, Kuiper H, Limburg PC, Kallenberg CG, Bijl M. Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients. Ann Rheum Dis. 2008 ; 67: 11-18
24. Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg CG, Bijl M. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Res Ther. 2011 ; 13: R71 - R71
25. Abdulahad DA, Westra J, Limburg PC, Kallenberg CG, Bijl M. HMGB1 in systemic lupus erythematosus: Its role in cutaneous lesions development. Autoimmun Rev. 2013 ; 9: 661-665
26. Hayashi A, Nagafuchi H, Ito I, Hirota K, Yoshida M, Ozaki S. Lupus antibodies to the HMGB1 chromosomal protein: Epitope mapping and association with disease activity. Mod Rheumatol. 2009 ; 19: 283-292
27. Li J, Xie H, Wen T, Liu H, Zhu W, Chen X. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol. 2013 ; 37: 766-775
28. Harris HE, Andersson U, Pisetsky DS. HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol. 2012 ; 8: 195-202
29. Abdulahad DA, Westra J, Bijzet J, et al. Urine levels of HMGB1 in systemic lupus erythematosus patients with and without renal manifestations. Arthritis Res Ther. 2012 ; 14: R184 - R184
30. Mikita N, Ikeda T, Ishiguro M, Furukawa F. Recent advances in cytokines in cutaneous and systemic lupus erythematosus. J Dermatol. 2011 ; 38: 839-849
31. Sun CL, Zhang FZ, Li P, Bi LQ. LL-37 expression in the skin in systemic lupus erythematosus. Lupus. 2011 ; 20: 904-911
32. Yanai H, Ban T, Wang Z, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 2009 ; 462: 99-103
33. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.